Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples